M&T Bank’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-132,715
| Closed | -$478K | – | 1530 |
|
|
2024
Q4 | $478K | Buy |
132,715
+18,808
| +17% | +$67.8K | ﹤0.01% | 1188 |
|
|
2024
Q3 | $649K | Buy |
113,907
+18,466
| +19% | +$105K | ﹤0.01% | 1066 |
|
|
2024
Q2 | $441K | Buy |
95,441
+10,631
| +13% | +$49.1K | ﹤0.01% | 1167 |
|
|
2024
Q1 | $692K | Sell |
84,810
-53,778
| -39% | -$439K | ﹤0.01% | 1013 |
|
|
2023
Q4 | $784K | Sell |
138,588
-1,432
| -1% | -$8.1K | ﹤0.01% | 961 |
|
|
2023
Q3 | $260K | Buy |
+140,020
| New | +$260K | ﹤0.01% | 1329 |
|
|
2023
Q2 | – | Sell |
-72,000
| Closed | -$226K | – | 1581 |
|
|
2023
Q1 | $226K | Buy |
72,000
+10,708
| +17% | +$33.6K | ﹤0.01% | 1416 |
|
|
2022
Q4 | $362K | Buy |
61,292
+10,142
| +20% | +$59.9K | ﹤0.01% | 1224 |
|
|
2022
Q3 | $448K | Sell |
51,150
-10,844
| -17% | -$95K | ﹤0.01% | 1134 |
|
|
2022
Q2 | $468K | Buy |
61,994
+44,646
| +257% | +$337K | ﹤0.01% | 1036 |
|
|
2022
Q1 | $420K | Buy |
17,348
+9,944
| +134% | +$241K | ﹤0.01% | 1061 |
|
|
2021
Q4 | $238K | Buy |
7,404
+1,447
| +24% | +$46.5K | ﹤0.01% | 1365 |
|
|
2021
Q3 | $266K | Sell |
5,957
-41
| -0.7% | -$1.83K | ﹤0.01% | 1295 |
|
|
2021
Q2 | $227K | Buy |
+5,998
| New | +$227K | ﹤0.01% | 1398 |
|